Peter C. Warnke
Impact in
Papers in
- Co-authors
- Christoph B. Ostertag (12 shared papers)Friedrich W. Kreth (8 shared papers)Zvi Ram (3 shared papers)Manfred Westphal (3 shared papers)Juha E. Jääskeläinen (2 shared papers)Robert Olivares (2 shared papers)Ian R. Whittle (2 shared papers)Dana Hilt (2 shared papers)
- Journals
- Neurosurgery (13 papers)Journal of Neuro-Oncology (9 papers)Neurology (8 papers)Journal of Neurology Neurosurgery & Psychiatry (8 papers)Acta Neurochirurgica (5 papers)
- Partner nations
- United StatesGermanyUnited Kingdom
In The Last Decade
Peter C. Warnke
130 papers receiving 4.9k citations
Peter C. Warnke's Hit Papers
Peers
Comparison fields: 5 of 129
- Genetics 2.1k
- Neurology 902
- Biomaterials 459
- Radiology, Nuclear Medicine and Imaging 605
- Cancer Research 372
Countries citing papers authored by Peter C. Warnke
This map shows the geographic impact of Peter C. Warnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Warnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Warnke more than expected).
Fields of papers citing papers by Peter C. Warnke
This network shows the impact of papers produced by Peter C. Warnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Warnke. The network helps show where Peter C. Warnke may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. Warnke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A phase 3 trial of local chemotherapy with biodegradable carmustine(BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma Hit paper breakdown → | 2003 | 1073 |
| 2 | 1995 | 435 | |
| 3 | 2014 | 237 | |
| 4 | 1993 | 194 | |
| 5 | 2013 | 188 | |
| 6 | 2014 | 131 | |
| 7 | 2003 | 130 | |
| 8 | 1999 | 97 | |
| 9 | 2013 | 95 | |
| 10 | 2006 | 86 | |
| 11 | 2018 | 80 | |
| 12 | 2006 | 78 | |
| 13 | 2003 | 77 | |
| 14 | 2017 | 75 | |
| 15 | 2012 | 70 | |
| 16 | 1997 | 69 | |
| 17 | 1991 | 65 | |
| 18 | 2011 | 64 | |
| 19 | 2005 | 59 | |
| 20 | 2017 | 58 |
About Peter C. Warnke
Peter C. Warnke is a scholar working on Genetics, Neurology, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging, having authored 132 papers that have together received 5.1k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (47 papers), Epilepsy research and treatment (20 papers), Brain Metastases and Treatment (16 papers), Neurological disorders and treatments (14 papers), Meningioma and schwannoma management (13 papers), Neuroscience and Neuropharmacology Research (9 papers), Cerebrospinal fluid and hydrocephalus (9 papers) and EEG and Brain-Computer Interfaces (8 papers). The work is most often cited by research in Genetics (2.1k citations), Neurology (902 citations), Biomaterials (459 citations), Radiology, Nuclear Medicine and Imaging (605 citations) and Cancer Research (372 citations). Peter C. Warnke has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Christoph B. Ostertag, Friedrich W. Kreth, Zvi Ram, Manfred Westphal, Juha E. Jääskeläinen, Robert Olivares, Ian R. Whittle, Dana Hilt, Patrick Delavault and Enoch Bortey. Their work appears in journals such as Neurosurgery, Journal of Neuro-Oncology, Neurology, Journal of Neurology Neurosurgery & Psychiatry and Acta Neurochirurgica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.